Quantitative detection of zeta-chain-associated protein 70 expression in chronic lymphocytic leukemia

References

• Hamblin TJ, Davis Z, Gardiner A, . Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848–1854.
   PubMed Web of Science ®Google Scholar
• Döhner H, Stilgenbauer S, Benner A, . Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910–1916.
   PubMed Web of Science ®Google Scholar
• Kröber A, Seiler T, Benner A, . V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002;100:1410–1416.
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S, Döhner H. Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy. N Engl J Med 2002;347:452–453.
   PubMed Web of Science ®Google Scholar
• Calin GA, Liu CG, Sevignani C, . MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004;101:11755–11760.
   PubMed Web of Science ®Google Scholar
• Calin GA, Ferracin M, Cimmino A, . A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005;353:1793–1801.
   PubMed Web of Science ®Google Scholar
• Moussay E, Wang K, Cho JH, . MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2011;108:6573–6578.
   PubMed Web of Science ®Google Scholar
• Corcoran M, Parker A, Orchard J, . ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia. Haematologica 2005;90:1078–1088.
   PubMed Web of Science ®Google Scholar
• Damle RN, Wasil T, Fais F, . IgVH gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840–1847.
   PubMed Web of Science ®Google Scholar
• Dürig J, Naschar M, Schmücker U, . CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia 2002;16:30–35.
   PubMed Web of Science ®Google Scholar
• Crespo M, Bosch F, Villamor N, . ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764–1775.
   PubMed Web of Science ®Google Scholar
• Wiestner A, Rosenwald A, Barry TS, . ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003;101:4944–4951.
   PubMed Web of Science ®Google Scholar
• Van Bockstaele F, Pede V, Janssens A, . Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia. Clin Chem 2007;53:204–212.
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Alizadeh AA, Widhopf G, . Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001;194:1639–1647.
   PubMed Web of Science ®Google Scholar
• Rassenti LZ, Huynh L, Toy TL, . ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351:893–901.
   PubMed Web of Science ®Google Scholar
• Klein U, Tu Y, Stolovitzky GA, . Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001;194:1625–1638.
   PubMed Web of Science ®Google Scholar
• Pryshchep S, Goronzy JJ, Parashar S, . Insufficient deactivation of the protein tyrosine kinase lck amplifies T-cell responsiveness in acute coronary syndrome. Circ Res 2010;106:769–778.
   PubMed Web of Science ®Google Scholar
• Stamatopoulos B, Meuleman N, Haibe-Kains B, . Quantification of ZAP-70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clin Chem 2007;53:1757–1766.
   PubMed Web of Science ®Google Scholar
• Stamatopoulos B, Haibe-Kains B, Equeter C, . Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP-70 mRNA. Haematologica 2009;94:790–799.
   PubMed Web of Science ®Google Scholar
• Carreras J, Villamor N, Colomo L, . Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms. J Pathol 2005;205:507–513.
   PubMed Web of Science ®Google Scholar
• Admirand JH, Knoblock RJ, Coombes KR, . Immunohistochemical detection of ZAP-70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression. Mod Pathol 2010;23:1518–1523.
   PubMed Web of Science ®Google Scholar
• Chen L, Widhopf G, Huynh L, . Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 2002;100:4609–4614.
   PubMed Web of Science ®Google Scholar
• Preobrazhensky SN, Bahler DW. Optimization of flow cytometric measurement of ZAP-70 in chronic lymphocytic leukemia. Cytometry B Clin Cytom 2008;74:118–127.
   PubMed Web of Science ®Google Scholar
• Zhu P, Shelton DR, Li S, . Detection of E. coli O157:H7 by immunomagnetic separation coupled with fluorescence immunoassay. Biosens Bioelectron 2011;30:337–341.
   PubMed Web of Science ®Google Scholar
• Zhu P, Shelton DR, Karns JS, . Detection of water-borne E. coli O157 using the integrating waveguide biosensor. Biosens Bioelectron 2005;21:678–683.
   PubMed Web of Science ®Google Scholar
• Degheidy HA, Venzon DJ, Farooqui MZ, . Methodological comparison of two anti-ZAP-70 antibodies. Cytometry B Clin Cytom 2011;80B:300–308.
   Web of Science ®Google Scholar
• Degheidy HA, Venzon DJ, Farooqui MZ, . Improved ZAP-70 assay using two clones, multiple methods of analysis and clinical correlation. Cytometry B Clin Cytom 2011;80B:309–317.
   Web of Science ®Google Scholar
• Orchard J, Ibbotson R, Best G, . ZAP-70 in B cell malignancies. Leuk Lymphoma 2005;46:1689–1698.
   PubMed Web of Science ®Google Scholar
• Sup SJ, Domiati-Saad R, Kelley TW, . ZAP-70 expression in B-cell hematologic malignancy is not limited to CLL/SLL. Am J Clin Pathol 2004;122:582–587.
   PubMed Web of Science ®Google Scholar
• Sloan-Lancaster J, Zhang W, Presley J, . Regulation of ZAP-70 intracellular localization: visualization with the green fluorescent protein. J Exp Med 1997;186:1713–1724.
   PubMed Web of Science ®Google Scholar
• Li S, Amstutz P, Tang CM, . Integrating waveguide biosensor. In: Rasooly A, Herold KE, editors. Biosensors and biodetection methods and protocols, Vol. 1: optical-based detectors. New York: Humana Press;2009. pp 89–401.
   Google Scholar
• Li S, Zhang Y, Amstutz P, . Multiplex integrating waveguide sensor – Signalyte™-II. In: Rasooly A, Herold KE, editors. Biosensors and biodetection methods and protocols, Vol. 1: Optical-based detectors. New York: Humana Press;2009. pp 423–434.
   Google Scholar
• Li S, Kiefer L, Zhu P, . Ultra-sensitive detection using integrated waveguide technologies. In: Somerset V, editor. Biosensors for health, environment and biosecurity, Book 3, Environmental biosensors. Rijeka, Croatia: InTech; 2011.
   Google Scholar
• Vroblova V, Vrbacky F, Hrudkova M, . Significant change in ZAP-70 expression during the course of chronic lymphocytic leukemia. Eur J Haematol 2010;84:513–517.
   PubMed Web of Science ®Google Scholar